ConditionBones, joints & muscles

Muscular Dystrophy

Muscular dystrophy (MD) is a group of more than 30 inherited diseases in which muscles gradually weaken and break down because of faulty genes for muscle proteins. The most common childhood type, Duchenne muscular dystrophy, affects boys, starting with clumsiness, frequent falls and difficulty climbing stairs around age 2 to 5. Other types, such as myotonic, Becker, facioscapulohumeral and limb-girdle dystrophy, can begin in adolescence or adulthood. There is no cure, but steroids, gene-targeted therapies and heart and breathing care have greatly extended life.

Also called: MD, dystrophinopathy, Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy

At a glance

What it is
Inherited diseases causing progressive muscle weakness and wasting.
Most common types
Duchenne (boys, early childhood), Becker (milder), myotonic (most common adult form), facioscapulohumeral and limb-girdle.
Early signs in Duchenne
Late walking, frequent falls, waddling gait, Gowers' sign, enlarged calves.
Diagnosis
Creatine kinase blood test, genetic testing, sometimes muscle biopsy.
Treatment
Corticosteroids, exon-skipping and gene therapies for eligible patients, physical therapy, heart and breathing care.

When to get help

Call 911 or go to the ER

  • Severe breathlessness, very shallow breathing, blue lips or confusion
  • Chest pain, fainting or a very irregular heartbeat

See a doctor within a day or two

  • A chest infection, weak cough or morning headaches and daytime sleepiness (possible breathing weakness at night)
  • Swallowing difficulty with choking or weight loss
  • Signs of adrenal crisis in someone on long-term steroids who is vomiting or unwell

Book a routine appointment

  • A toddler who walks late, falls often, has trouble running or climbing stairs, or uses hands to push up from the floor
  • A creatine kinase (CK) level found to be very high
  • Adults with progressive weakness, muscle stiffness that is slow to relax, or a family history of muscular dystrophy

What causes muscular dystrophy

Each type is caused by changes in a gene needed for healthy muscle fibers. In Duchenne and Becker, the gene affected makes dystrophin, a protein that stabilizes muscle cell membranes during contraction. Without it, muscle fibers are damaged with use and gradually replaced by fat and scar tissue.

Inheritance patterns vary:

  • X-linked: Duchenne and Becker mainly affect boys. Mothers may be carriers. About a third of Duchenne cases arise from new mutations
  • autosomal dominant: myotonic dystrophy, facioscapulohumeral dystrophy, some limb-girdle types
  • autosomal recessive: many limb-girdle and congenital types

Main types

TypeTypical onsetKey features
Duchenne (DMD)Age 2 to 5, boysRapid progression, loss of walking around age 10 to 14 without treatment, heart and breathing involvement
Becker (BMD)Childhood to adulthoodMilder, slower, walking often maintained into adulthood, heart disease common
Myotonic dystrophyTeens to adulthoodMuscle stiffness that is slow to relax (myotonia), facial and hand weakness, cataracts, heart rhythm problems, diabetes
Facioscapulohumeral (FSHD)Teens to adulthoodFace, shoulder blade and upper arm weakness, often uneven
Limb-girdle (LGMD)Childhood to adulthoodHip and shoulder weakness
CongenitalBirth or infancyLow tone, joint contractures, sometimes brain involvement
Emery-DreifussChildhoodEarly contractures, heart conduction problems
OculopharyngealOver 40Drooping eyelids, swallowing difficulty

Symptoms

Duchenne muscular dystrophy

  • late walking (after 18 months)
  • frequent falls, clumsiness, difficulty running and jumping
  • waddling gait and walking on toes
  • Gowers' sign: using the hands to "walk up" the legs to stand from the floor
  • enlarged calf muscles (pseudohypertrophy)
  • learning and speech delays in some boys (developmental delays)
  • progressive muscle weakness, loss of walking, scoliosis
  • heart muscle disease (cardiomyopathy) and breathing muscle weakness in teens and adults

Other types

Symptoms depend on which muscles are affected and may include weakness of the face, shoulders, hips or hands, muscle stiffness, drooping eyelids, swallowing difficulty, heart rhythm problems and fatigue.

Diagnosis

  • creatine kinase (CK) blood test: very high in Duchenne and Becker, often 10 to 100 times normal
  • genetic testing: confirms the type and specific mutation, which determines eligibility for targeted therapies
  • muscle biopsy: sometimes, to examine protein levels
  • electromyography (EMG) and nerve studies in some adult forms
  • heart tests: ECG, echocardiogram and cardiac MRI
  • breathing tests: lung function and sleep studies
  • carrier testing for female relatives in X-linked types

Some US states and countries are adding Duchenne to newborn screening programs.

Treatment

Care is coordinated by a neuromuscular specialist team.

Medicines

  • corticosteroids (prednisone, deflazacort) or vamorolone slow muscle decline in Duchenne and delay loss of walking
  • exon-skipping therapies (such as eteplirsen, golodirsen, viltolarsen, casimersen) for boys with specific mutations
  • gene therapy (delandistrogene moxeparvovec) for selected patients with Duchenne
  • givinostat for Duchenne
  • heart medicines such as ACE inhibitors and beta blockers to protect the heart
  • mexiletine for myotonia in myotonic dystrophy

Supportive care

  • physical therapy and stretching to delay contractures
  • night splints, braces and wheelchairs
  • scoliosis surgery when needed
  • breathing support: cough assist devices and non-invasive ventilation (BiPAP), often at night first, to prevent respiratory failure
  • bone health: vitamin D, calcium, bisphosphonates
  • nutrition, swallowing support and weight management
  • psychological, educational and social support

Outlook

Outlook depends on the type. With modern care, people with Duchenne now commonly live into their 30s and beyond, compared with late teens in earlier decades. Becker, myotonic and facioscapulohumeral dystrophies usually have a near-normal or modestly reduced life span, with variable disability.

Frequently asked questions

What is muscular dystrophy?

Muscular dystrophy is a group of inherited diseases in which faulty genes for muscle proteins cause muscles to weaken and waste away over time. There are more than 30 types, differing in age of onset, muscles affected and speed of progression.

What are the first signs of muscular dystrophy?

In Duchenne, early signs include late walking, frequent falls, difficulty running or climbing stairs, a waddling gait, toe walking, enlarged calves and using the hands to push up from the floor. Adult forms may start with hand, face or shoulder weakness.

Is muscular dystrophy inherited?

Yes. Duchenne and Becker are X-linked and mainly affect boys, with mothers often carriers. Other types are passed on in dominant or recessive patterns. Some cases arise from new mutations without family history.

What is the life expectancy with muscular dystrophy?

It varies by type. With modern care, many people with Duchenne live into their 30s or longer. Becker and many adult-onset types have near-normal or modestly reduced life expectancy. Heart and breathing care are key.

Can muscular dystrophy be cured?

There is no cure yet. Corticosteroids, exon-skipping drugs and gene therapy can slow Duchenne progression in eligible patients. Physical therapy, heart medicines and breathing support help all types. Research is advancing rapidly.

Sources

This guide was written from current patient and clinical guidance, including:

  • National Institute of Neurological Disorders and Stroke (NINDS): Muscular dystrophy
  • CDC: Muscular dystrophy; Duchenne/Becker care considerations (2018)
  • Muscular Dystrophy Association (MDA): Types of muscular dystrophy
  • Parent Project Muscular Dystrophy: Care guidelines
  • MedlinePlus Genetics: Duchenne and Becker muscular dystrophy